13F Insight
DOSSIER · 13F Holders · Q3 2025Healthcare · BiotechnologyBellwetherCompounder
VRNA

VERONA PHARMA PLC

8 institutions still hold VERONA PHARMA PLC as of Q3 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 925050106·Biotechnology·8 13F holders·last filed Sep 30, 2025
Market cap
—
▲ 1.8%
vs prior quarter
13F value held
$16M
59.0% inst. owned
of float
Holders
8
+43 QoQ
filers reporting
Activity
+8 / −81
+806 added · −754 reduced
this quarter
Concentration
42.34%
Burren Capital Advisors Ltd #1
top holder share
AI Holders Summary · Q3 2025

8 institutions reported VRNA in Q3 2025. Burren Capital Advisors Ltd leads at 42.3% of the visible book. +43 net new institutions vs prior quarter — accumulation reading.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Burren Capital Advisors Ltd
CIK 0001542952
$7M63K20.43%Q3 202502
Alerce Investment Management, L.P.
CIK 0001844002
$4M88K7.19%Q4 202403
WOLVERINE TRADING, LLC
CIK 0000927337
$3M27K0.00%Q3 202504
CAXTON ASSOCIATES LP
CIK 0000872573
$1M30K0.04%Q4 202405
Cahill Wealth Management, LLC
CIK 0001927960
$511,7298K0.26%Q1 202506
Orion Portfolio Solutions, LLC
CIK 0001802647
$248,7544K0.00%Q1 202507
First Horizon Advisors, Inc.
CIK 0001588539
$107,9151K0.00%Q2 202508
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025